Serum decoy receptor 3 (DcR3) concentrations and associations with clinical parameters in Plasmodium vivax and Plasmodium falciparum malaria
- 1Department of Microbiology, Faculty of Medicine, Srinakharinwirot University, 114 Sukhumvit 23, Bangkok, 10110 Thailand
- 2Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol Univerity, 420/6 Rajvithi Road, Bangkok, 10400 Thailand
Abstract
Background: Decoy receptor (DcR3) is a soluble member of the tumor necrosis factor receptor superfamily with immunomodulatory properties that is elevated in several inflammatory and infectious diseases. However, its role in malaria remains poorly understood. This study investigated serum DcR3 concentrations in patients with Plasmodium vivax and Plasmodium falciparum malaria and evaluate the associations between DcR3 concentrations and clinical parameters.
Methods: This retrospective secondary analysis utilized archived serum samples and associated clinical data from two previously conducted malaria cohort studies. Seventy-six malaria patients were included: P. vivax (n = 36), uncomplicated P. falciparum (n = 30), and severe P. falciparum (n = 10), together with 20 healthy controls. Serum DcR3 concentrations were measured by enzyme-linked immunosorbent assay (ELISA) at hospital admission (Day 0) and after treatment (Day 7). Differences in DcR3 concentrations, associations with clinical parameters, and longitudinal changes across malaria groups were evaluated.
Results: At admission, serum DcR3 concentrations were significantly elevated in all malaria groups compared with healthy controls, with the highest concentrations observed in patients with severe P. falciparum malaria. Following treatment, DcR3 concentrations declined significantly in all malaria groups. Longitudinal analysis demonstrated no statistical evidence of differences in DcR3 decline patterns among malaria groups. However, DcR3 concentrations remained elevated in patients with severe P. falciparum malaria compared with healthy controls at Day 7. DcR3 concentrations correlated positively with parasite density in uncomplicated and severe P. falciparum malaria and inversely with platelet count in P. vivax malaria.
Conclusion: Serum DcR3 concentrations were elevated during acute malaria infection and decreased following treatment. Patients with severe P. falciparum malaria had higher DcR3 concentrations compared with other malaria groups; however, the longitudinal decline in DcR3 concentrations was comparable among groups. These findings are exploratory due to the retrospective study design and limited number of patients with severe malaria and require validation in larger prospective cohorts.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12936-026-06100-x.
Related
- Plasmodium falciparum histidine rich protein 2 plasma concentrations from uncomplicated and severe malaria patients estimated by rapid test band intensity.
- FIKK1, a member of the FIKK kinase family, phosphorylates VAR2CSA and regulates adhesion of Plasmodium falciparum-infected erythrocytes to the placental receptor CSA
- Surveillance de l’efficacité des associations artémether-luméfantrine et artésunate/sulfadoxine-pyriméthamine dans le traitement du paludisme simple à Plasmodium falciparum à Boali, République centrafricaine
- Acute Pancreatitis as a Rare Complication of Plasmodium falciparum Malaria: A Case Report
- Human hemoglobin protects the parasite cytoskeleton during Plasmodium falciparum gametocyte development
BibTeX
@article{nantavisai2026serum,
title = {{Serum decoy receptor 3 (DcR3) concentrations and associations with clinical parameters in Plasmodium vivax and Plasmodium falciparum malaria}},
author = {Kwannan Nantavisai and Srisombat Puttikamonkul and Parnpen Viriyavejakul},
journal = {Malaria Journal},
year = {2026},
month = aug,
doi = {10.1186/s12936-026-06100-x},
url = {https://doi.org/10.1186/s12936-026-06100-x},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Serum decoy receptor 3 (DcR3) concentrations and associations with clinical parameters in Plasmodium vivax and Plasmodium falciparum malaria
AU - Kwannan Nantavisai
AU - Srisombat Puttikamonkul
AU - Parnpen Viriyavejakul
PY - 2026
DA - 2026/08/08
JO - Malaria Journal
DO - 10.1186/s12936-026-06100-x
UR - https://doi.org/10.1186/s12936-026-06100-x
AB - Background: Decoy receptor (DcR3) is a soluble member of the tumor necrosis factor receptor superfamily with immunomodulatory properties that is elevated in several inflammatory and infectious diseases. However, its role in malaria remains poorly understood. This study investigated serum DcR3 concentrations in patients with Plasmodium vivax and Plasmodium falciparum malaria and evaluate the associations between DcR3 concentrations and clinical parameters. Methods: This retrospective secondary analysis utilized archived serum samples and associated clinical data from two previously conducted malaria cohort studies. Seventy-six malaria patients were included: P. vivax (n = 36), uncomplicated P. falciparum (n = 30), and severe P. falciparum (n = 10), together with 20 healthy controls. Serum DcR3 concentrations were measured by enzyme-linked immunosorbent assay (ELISA) at hospital admission (Day 0) and after treatment (Day 7). Differences in DcR3 concentrations, associations with clinical parameters, and longitudinal changes across malaria groups were evaluated. Results: At admission, serum DcR3 concentrations were significantly elevated in all malaria groups compared with healthy controls, with the highest concentrations observed in patients with severe P. falciparum malaria. Following treatment, DcR3 concentrations declined significantly in all malaria groups. Longitudinal analysis demonstrated no statistical evidence of differences in DcR3 decline patterns among malaria groups. However, DcR3 concentrations remained elevated in patients with severe P. falciparum malaria compared with healthy controls at Day 7. DcR3 concentrations correlated positively with parasite density in uncomplicated and severe P. falciparum malaria and inversely with platelet count in P. vivax malaria. Conclusion: Serum DcR3 concentrations were elevated during acute malaria infection and decreased following treatment. Patients with severe P. falciparum malaria had higher DcR3 concentrations compared with other malaria groups; however, the longitudinal decline in DcR3 concentrations was comparable among groups. These findings are exploratory due to the retrospective study design and limited number of patients with severe malaria and require validation in larger prospective cohorts. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12936-026-06100-x.
SN - 1475-2875
ER -